I was the one who spoke to Paul Lammers, CEO of Mirna, last week. It was an interesting phone call and I'll explain why.
French and Lammers had lunch together at the JPM Conference in San Francisco. The last time Lammers had saw French personally was at a conference in Japan in October.
Now, I was surprised to hear from Lammers that French looked "down in the dump" at least in respect to his last run in with him in Japan. Apparently, French told him they are still looking to secure financing and were talking to several interested parties (not sure who). I asked if French mentioned bankruptcy at all and he said "no."
Furthermore, there seems to be something perhaps sinister going on behind the scenes in regards to Smarticles. Lammers said Smarticles worked amazing for his company and ProNai, but neither have touted it in any of their Press Releases. For whatever reason, he also tried to downplay Smarticles as a viable asset for big pharma and said "it just doesn't work for them." Is he trying to create misinformation to start a bidding war.
Towards the end of the call I asked about the ability of Marina to restore shareholder value despite their bleak situation. Lammers replied, "Perhaps there is something we can do on our end that will help Marina shareholders." I found that part very intriguing.